219 related articles for article (PubMed ID: 8000304)
1. Analysis of cytochrome P450 2E1 genetic polymorphisms in relation to human lung cancer.
Kato S; Shields PG; Caporaso NE; Sugimura H; Trivers GE; Tucker MA; Trump BF; Weston A; Harris CC
Cancer Epidemiol Biomarkers Prev; 1994 Sep; 3(6):515-8. PubMed ID: 8000304
[TBL] [Abstract][Full Text] [Related]
2. Cytochrome P450IIE1 genetic polymorphisms, racial variation, and lung cancer risk.
Kato S; Shields PG; Caporaso NE; Hoover RN; Trump BF; Sugimura H; Weston A; Harris CC
Cancer Res; 1992 Dec; 52(23):6712-5. PubMed ID: 1423319
[TBL] [Abstract][Full Text] [Related]
3. Cytochrome P450 2E1 DraI polymorphisms in lung cancer in minority populations.
Wu X; Amos CI; Kemp BL; Shi H; Jiang H; Wan Y; Spitz MR
Cancer Epidemiol Biomarkers Prev; 1998 Jan; 7(1):13-8. PubMed ID: 9456237
[TBL] [Abstract][Full Text] [Related]
4. Ethnic variation in the CYP2E1 gene: polymorphism analysis of 695 African-Americans, European-Americans and Taiwanese.
Stephens EA; Taylor JA; Kaplan N; Yang CH; Hsieh LL; Lucier GW; Bell DA
Pharmacogenetics; 1994 Aug; 4(4):185-92. PubMed ID: 7987402
[TBL] [Abstract][Full Text] [Related]
5. Lung cancer risk in relation to the CYP2E1 Rsa I genetic polymorphism among African-Americans and Caucasians in Los Angeles County.
London SJ; Daly AK; Cooper J; Carpenter CL; Navidi WC; Ding L; Idle JR
Pharmacogenetics; 1996 Apr; 6(2):151-8. PubMed ID: 9156693
[TBL] [Abstract][Full Text] [Related]
6. Impact of CYP2E1 genotype in renal cell and urothelial cancer patients.
Farker K; Lehmann MH; Oelschlägel B; Haerting J; Hoffmann A; Janitzky V; Schubert J
Exp Toxicol Pathol; 1998 Sep; 50(4-6):425-31. PubMed ID: 9784018
[TBL] [Abstract][Full Text] [Related]
7. Cytochrome P4502E1 genetic polymorphisms and risk of nasopharyngeal carcinoma: results from a case-control study conducted in Taiwan.
Hildesheim A; Chen CJ; Caporaso NE; Cheng YJ; Hoover RN; Hsu MM; Levine PH; Chen IH; Chen JY; Yang CS
Cancer Epidemiol Biomarkers Prev; 1995 Sep; 4(6):607-10. PubMed ID: 8547826
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphism of cytochrome P4502E1 in a Swedish population. Relationship to incidence of lung cancer.
Persson I; Johansson I; Bergling H; Dahl ML; Seidegård J; Rylander R; Rannug A; Högberg J; Sundberg MI
FEBS Lett; 1993 Mar; 319(3):207-11. PubMed ID: 8096192
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of cytochrome P450 2E1 RsaI/PstI and DraI polymorphisms in workers exposed to benzene].
Chen Z; Ling J; Liu Y; Wu X; Wang D; Wang J; Tu H
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2015 Aug; 33(8):595-7. PubMed ID: 26653810
[TBL] [Abstract][Full Text] [Related]
10. Elucidation of CYP2E1 5' regulatory RsaI/Pstl allelic variants and their role in risk for oral cancer.
Liu S; Park JY; Schantz SP; Stern JC; Lazarus P
Oral Oncol; 2001 Jul; 37(5):437-45. PubMed ID: 11377232
[TBL] [Abstract][Full Text] [Related]
11. CYP2E1 genotyping in renal cell/urothelial cancer patients in comparison with control populations.
Farker K; Lehmann MH; Kästner R; Hoffmann A; Janitzky V; Schubert J; Matz U; Hofmann W
Int J Clin Pharmacol Ther; 1998 Sep; 36(9):463-8. PubMed ID: 9760005
[TBL] [Abstract][Full Text] [Related]
12. Functional PstI/RsaI polymorphism in CYP2E1 is associated with the development, progression and poor outcome of gastric cancer.
Feng J; Pan X; Yu J; Chen Z; Xu H; El-Rifai W; Zhang G; Xu Z
PLoS One; 2012; 7(9):e44478. PubMed ID: 22957075
[TBL] [Abstract][Full Text] [Related]
13. Human cytochrome P450IIE1 gene: DraI polymorphism and susceptibility to cancer.
Uematsu F; Kikuchi H; Motomiya M; Abe T; Ishioka C; Kanamaru R; Sagami I; Watanabe M
Tohoku J Exp Med; 1992 Oct; 168(2):113-7. PubMed ID: 1363974
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphism of cytochrome P450 2E1 in the Turkish population.
Omer B; Ozbek U; Akköse A; Kiliç G
Cell Biochem Funct; 2001 Dec; 19(4):273-5. PubMed ID: 11746208
[TBL] [Abstract][Full Text] [Related]
15. Cytochrome P450 2E1 RsaI/PstI and DraI Polymorphisms Are Risk Factors for Lung Cancer in Mongolian and Han Population in Inner Mongolia.
Su XL; Bin B; Cui HW; Ran MR
Chin J Cancer Res; 2011 Jun; 23(2):107-11. PubMed ID: 23483202
[TBL] [Abstract][Full Text] [Related]
16. Association of combined CYP2E1 gene polymorphism with the risk for esophageal squamous cell carcinoma in Huai'an population, China.
Liu R; Yin LH; Pu YP
Chin Med J (Engl); 2007 Oct; 120(20):1797-802. PubMed ID: 18028774
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms of CYP2E1 and GSTM1 in a Thai population.
Sangrajrang S; Jedpiyawongse A; Srivatanakul P
Asian Pac J Cancer Prev; 2006; 7(3):415-9. PubMed ID: 17059334
[TBL] [Abstract][Full Text] [Related]
18. An investigation of whether polymorphisms of cytochrome P4502E1 are genetic markers of susceptibility to alcoholic end-stage organ damage in a Chinese population.
Chao YC; Young TH; Chang WK; Tang HS; Hsu CT
Hepatology; 1995 Nov; 22(5):1409-14. PubMed ID: 7590656
[TBL] [Abstract][Full Text] [Related]
19. The PstI/RsaI and DraI polymorphisms of CYP2E1 and head and neck cancer risk: a meta-analysis based on 21 case-control studies.
Tang K; Li Y; Zhang Z; Gu Y; Xiong Y; Feng G; He L; Qin S
BMC Cancer; 2010 Oct; 10():575. PubMed ID: 20969746
[TBL] [Abstract][Full Text] [Related]
20. Cytochrome P450 2E1 and glutathione S-transferase M1 polymorphisms and susceptibility to hepatocellular carcinoma.
Yu MW; Gladek-Yarborough A; Chiamprasert S; Santella RM; Liaw YF; Chen CJ
Gastroenterology; 1995 Oct; 109(4):1266-73. PubMed ID: 7557094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
